S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Change in Working Capital
kr3.6m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Change in Working Capital
-kr47.5B
CAGR 3-Years
-50%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
H Lundbeck A/S
CSE:HLUN A
Change in Working Capital
-kr1.4B
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Change in Working Capital
-kr263m
CAGR 3-Years
-16%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Change in Working Capital?
Change in Working Capital
3.6m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Change in Working Capital amounts to 3.6m DKK.

What is Stenocare A/S's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
24%

The average annual Change in Working Capital growth rates for Stenocare A/S have been 24% over the past three years .

Back to Top